VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma. Cancer. 2016 09 01; 122(17):2680-8.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Azacitidine
Busulfan
Child
Deoxycytidine
Drug Resistance, Neoplasm
Epigenesis, Genetic
Female
Follow-Up Studies
Humans
Hydroxamic Acids
Lymphoma
Male
Melphalan
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Survival Rate
Young Adult
authors with profiles
RICHARD E CHAMPLIN
PETER F THALL
BORJE S ANDERSSON
PAOLO ANDERLINI
UDAY R POPAT
BOUTHAINA SHBIB DABAJA
CHITRA HOSING
MICHELLE A FANALE
ELIZABETH SHPALL
MUZAFFAR H QAZILBASH
YASUHIRO OKI
BENIGNO VALDEZ
AMIN MAJID ALOUSI
YAGO NIETO
CHELSEA CAMILLE PINNIX
QAISER BASHIR
SAIRAH AHMED